Bone Therapeutics S.A. allogeneic osteoblastic cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bone Therapeutics S.A. allogeneic osteoblastic cells, covering 2021-09-28 to 2021-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures [Phase 1, Phase 2]